AIDS in the World II

Jonathan M. Mann, M.D., M.P.H., is Francois-Xavier Bagnoud Professor of Health and Human Rights, Professor of Epidemiology and International Health, and Director of the Francois-Xavier Bagnoud Center for Health and Human Rights at Harvard University School of Public Health. Daniel J.M. Tarantola, M.D., is Senior Research Associate, Lecturer in Population and International Health, and Director of the International AIDS Program atthe Francois-Xavier Bagnoud Center for Health and Human Rights, Harvard University School of Public Health.

• Part I: The State of the Pandemic and its Impact ; 1. A Global Overview ; 2. The Dynamic HIV/AIDS Pandemic ; 3. The Evolving HIV/AIDS Pandemic ; 4. The Spread of HIV and Sexual Mixing Patterns ; 5. The Pandemic of HIV-Associated Tuberculosis ; 6. HIV/AIDS Among Women ; 7. The Economic Impact ; 8. Societal and Political Impact of HIV/AIDS ; Part II: The Frontiers of Knowledge ; 9. YThe Contribution of Social and Behavioral Science to HIV/AIDS Prevention ; 10. Treatment of HIV Disease: Problems, Progress, and Potential ; 11. Long-Term Survivors: What Can We Learn From Them? ; 12. HIV-2 Infection: Current Knowldge and Uncertainties ; 13. HIV Heterogeneity in Transmission and Pathogenesis ; 14. HIV Vaccine Development: Progress and Problems ; 15. Preparing for HIV Vaccine Efficacy Trials in Developing Countries ; 16. Women-Controlled HIV Prevention Methods ; 17. Who Sets the Global Research Agenda for Biomedical Science? ; 18. AIDS Research: Solidarity? Rivalry? Fraternity? ; Part III: Individual and Population Responses ; 19. HIV/AIDS Among Women ; 20. HIV in Women: What are the Gaps in Knowledge ; 21. Youth and HIV/AIDS ; 22. Homosexuality and HIV ; 23. Sexual Behavior Among Heterosexuals ; 24. Risk Reduction Among Injecting Drug Users ; 25. HIV.AIDS in Prison ; 26. Pediatric HIV/AIDS ; 27. Orphans of the HIV/AIDS Pandemic ; 28. Blood and Blood Product Safety ; 29. Are We Learning from the Lessons of the Past? ; Part IV: Collective Responses ; 30. Governmental National AIDS Programs ; 31. Human Rights and Responses to HIV/AIDS ; 32. Nongovernmental Organizations ; 33. The Private Sector: How are Corporations Responding to HIV/AIDS? ; 34. The UN Response ; 35. International Funding of the Global AIDS Strategy: Official Development Assistance ; 36. The Cost of HIV/AIDS Care ; 37. Global Spending opn HIV/AIDS Prevention, Care, and Research Estimated Spendinbg on HIV Prevention ; Part V: From Epidemiology to Vulnerability to Human Rights ; 38. The History of Discovery and Response ; 39. Personal Vulnerability and the Design of thje Programs ; 40. Societal Vulnerability : The Contextual Analysis ; 41. From Vulnerability to Human Rights ; Appendix A: AIDS Cases Reported to the World Health Organization, by GAA and by Year, 1984-1996 ; Appendix B: Method for the Estimation and Projection of HIV/AIDS ; Appendix C: Repsonses to the Survey of Government National AIDS Programs ; Appendix D: Laws and Practices in Relation to HIVB/AIDS: A Survey of Government National AIDS Program Managers ; Appendix E: The Universal Declaration of Human Rights ; Appendix F: Directory of Contact of Government National AIDS Programs

Praise for the first volume: "No one can remain illiterate about HIV/AIDS -- a new phenomenon in our time. This authoritative compilation of valuable information and understandable concepts is an invaluable source for non-spcecialists and specialists alike." -- Jonas Salk, M.D.